National Newborn Screening for cystic fibrosis in the Republic of Ireland: genetic data from the first 6.5 years

[1]  C. Castellani,et al.  ECFS best practice guidelines: the 2018 revision. , 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[2]  O. Sommerburg,et al.  The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe. , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[3]  A. Munck,et al.  Cystic Fibrosis Transmembrane Conductance Regulator‐Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis , 2017, The Journal of pediatrics.

[4]  B. Ramsey,et al.  New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator. , 2016, Pediatric clinics of North America.

[5]  N. Derichs,et al.  Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[6]  Matthias Griese,et al.  A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. , 2011, The New England journal of medicine.

[7]  J. Dankert-Roelse,et al.  Newborn screening for cystic fibrosis: pros and cons , 2011, Breathe.

[8]  M. Rosenberg,et al.  Diagnosis of cystic fibrosis in the Republic of Ireland: epidemiology and costs. , 2007, Irish medical journal.

[9]  L. Curnow,et al.  Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing , 2005, Archives of Disease in Childhood.

[10]  T J David,et al.  Newborn Screening for Cystic Fibrosis , 2004, Journal of the Royal Society of Medicine.

[11]  A. Zolin,et al.  ECFS Patient Registry : annual data Report : 2013 data , 2016 .

[12]  Henri Dunantstraat.  Newborn screening for cystic fibrosis: pros and cons , 2011 .